bisoprolol has been researched along with Cancer of Prostate in 1 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higashiyama, A | 1 |
| Yokoyama, T | 1 |
| Omoto, Y | 1 |
| Habe, K | 1 |
| Yamanaka, K | 1 |
| Mizutani, H | 1 |
1 other study available for bisoprolol and Cancer of Prostate
| Article | Year |
|---|---|
Flutamide-induced photoleukomelanoderma.
Topics: Administration, Cutaneous; Aged; Androgen Antagonists; Benzimidazoles; Biopsy; Biphenyl Compounds; B | 2016 |